Key result
Severe functional TR after the Ross procedure resolves spontaneously in ~93% without compromising 10-year survival.
Why the study?
The natural history, predictors, and clinical outcomes of de novo severe functional tricuspid regurgitation following the Ross procedure needed to be characterized.
Does the development of de novo severe functional tricuspid regurgitation within 6 months after the Ross procedure resolve spontaneously or adversely affect long-term survival and freedom from valve reintervention in adult patients?
Cohort (n=699)
No
Does the development of de novo severe functional tricuspid regurgitation within 6 months after the Ross procedure resolve spontaneously or adversely affect long-term survival and freedom from valve reintervention in adult patients?
Answers are grounded in this paper and cite their sources.
De novo severe functional tricuspid regurgitation occurs in 8.7% of adults shortly after the Ross procedure, particularly in females, diabetics, and those with higher baseline TR or lower LVEF, but resolves spontaneously in over 93% of patients by 3 years without impairing 10-year survival or reintervention rates, supporting conservative surveillance over early tricuspid intervention.
Objective: To characterize the natural history, predictors, and clinical outcomes of de novo severe functional tricuspid regurgitation (TR) following the Ross procedure. Methods: At a single institution, 699 consecutive adults without preoperative severe TR undergoing the Ross procedure between 2011 and 2025 were reviewed. De novo severe TR was defined as TR grade ≥3 within 6 months postoperatively. Propensity score overlap weighting was used to balance 21 covariates between patients who developed de novo severe TR and those who did not. Weighted generalized estimating equations were used to analyze longitudinal TR trajectories. Predictors were identified using LASSO regression. Survival and reintervention were compared using weighted Kaplan-Meier and Aalen-Johansen methods. Conclusions: De novo severe TR after the Ross procedure is common but transient, resolving spontaneously without any adverse impact on survival or need for reintervention. These findings support a conservative management strategy with echocardiographic surveillance.
No takes yet. Share an insight, caveat, or question.
Sarshoghi et al. (2026) conducted a cohort in Aortic valve disease undergoing the Ross procedure (n=699). De novo severe functional tricuspid regurgitation (TR grade >=3 within 6 months postoperatively) vs. No de novo severe functional tricuspid regurgitation within 6 months postoperatively (control group) was evaluated on Incidence and spontaneous resolution of de novo severe functional tricuspid regurgitation (TR grade >=3 within 6 months improving to grade <3) (95% CI 85.4%-98.5%, p=<0.001). De novo severe functional tricuspid regurgitation occurred in 8.7% of Ross procedure patients, resolved spontaneously in 93.4% by 3 years, and did not affect 10-year survival.
Synapse has enriched 10 related papers. Consider them for comparative context: